Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …

Objective Osteoarthritis (OA) of the knee causes significant morbidity and current medical
treatment is limited to symptom relief, while therapies able to slow structural damage remain …

… Allen D Sawitzke1, … John D Bradley6, … Correspondence to Dr Allen D Sawitzke,
University of Utah School of Medicine, 30E 1900 S SOM 4B200, Salt Lake City UT 84132, USA; …

Objective. Treatment for gastrointestinal tract (GIT) disease in systemic sclerosis (SSc) is
challenging as no immunosuppressive or anti-fibrotic therapy is available with clearly proven …

Objective. To explore the relationship between fatigue and work productivity loss (WPL) in
people with psoriatic arthritis (PsA). Methods. Data were collected from participants in the …

The purpose of this study was to analyze antinuclear antibody (ANA) screening by enzyme-linked
immunosorbent assay (ELISA) followed by indirect fluorescent antibody (IFA) testing to …

Osteoarthritis (OA) is a chronic, highly prevalent and disabling disease that is expected to
increase in prevalence secondary to longer life expectancy and a disproportionately aging …

Pruritus is a common symptom in systemic sclerosis (SSc), an autoimmune disease which
causes fibrosis and vasculopathy in skin, lung, and gastrointestinal tract (GIT). Unfortunately, …

This report describes 2 patients with longstanding seropositive rheumatoid arthritis (RA) treated
with oral methotrexate (MTX) who developed large cell lymphoma of B cell phenotype. In …

Objective. The main histopathological focus of systemic sclerosis (SSc) has concentrated on
fibrotic changes. We investigated the microvasculature alterations in the skin of patients with …